1. AB0939 Off-label secukinumab dose escalation in the treatment of moderate-to-severe psoriasis: a multicenter, retrospective study. (12th June 2018) Authors: Phung, M.; Ighani, A.; Georgakopoulos, J.R.; Vender, R.; Giroux, L.; Lansang, P.; Yeung, J. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1594 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Biologic switching between interleukin 17A antagonists secukinumab and ixekizumab: a 12‐week, multicenter, retrospective study. (20th June 2018) Authors: Georgakopoulos, J.R.; Phung, M.; Ighani, A.; Lam, K.; Yeung, J. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 33:Number 1(2019) Page Start: e7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Comparative 12‐week effectiveness and safety outcomes of biologic agents ustekinumab, secukinumab and ixekizumab for the treatment of plaque psoriasis: a real‐world multicenter retrospective study. (8th May 2020) Authors: Georgakopoulos, J.R.; Lam, K.; Sandhu, V.K.; Ighani, A.; Phung, M.; Piguet, V.; Yeung, J. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 34:Number 8(2020) Page Start: e416 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Efficacy and safety of secukinumab in treating moderate to severe plaque psoriasis in two real‐world Canadian dermatology clinics: a multicenter retrospective study. (2nd August 2017) Authors: Georgakopoulos, J.R.; Ighani, A.; Zhou, L.L.; Yeung, J. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 32:Number 1(2018) Page Start: e32 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Long‐term 52‐week trends in apremilast safety outcomes for treatment of psoriasis in clinical practice: a multicentre, retrospective case series. (10th October 2018) Authors: Ighani, A.; Georgakopoulos, J.R.; Shear, N.H.; Walsh, S.; Yeung, J. Journal: British journal of dermatology Issue: Volume 180:Number 1(2019) Page Start: 211 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Long‐term 52‐week trends in apremilast safety outcomes for treatment of psoriasis in clinical practice: a multicentre, retrospective case series. (1st January 2019) Authors: Ighani, A.; Georgakopoulos, J.R.; Shear, N.H.; Walsh, S.; Yeung, J. Journal: British journal of dermatology Issue: Volume 180:Number 1(2019) Page Start: 211 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Pyoderma gangrenosum and its impact on quality of life: a multicentre, prospective study. (1st March 2019) Authors: Ighani, A.; Al‐Mutairi, D.; Rahmani, A.; Weizman, A.V.; Piguet, V.; Alavi, A. Journal: British journal of dermatology Issue: Volume 180:Number 3(2019) Page Start: 672 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Pyoderma gangrenosum and its impact on quality of life: a multicentre, prospective study. (23rd November 2018) Authors: Ighani, A.; Al‐Mutairi, D.; Rahmani, A.; Weizman, A.V.; Piguet, V.; Alavi, A. Journal: British journal of dermatology Issue: Volume 180:Number 3(2019) Page Start: 672 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗